MXD3 and cancer: However, insufficient scientific evidence on the pathogenic roles of MXD3 in various cancers and whether MXD3 plays roles in the immune microenvironment and pathogenesis of different tumors through certain common molecular mechanisms and regulates therapy response were the rationalization for the present in silico pan-cancer study.